PMID- 19360113 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20120925 LR - 20211020 IS - 1687-4757 (Print) IS - 1687-4765 (Electronic) VI - 2009 DP - 2009 TI - The role of the PGC1alpha Gly482Ser polymorphism in weight gain due to intensive diabetes therapy. PG - 649286 LID - 10.1155/2009/649286 [doi] LID - 649286 AB - The Diabetes Control and Complications Trial (DCCT) involved intensive diabetes therapy of subjects with type 1 diabetes mellitus (T1DM) for an average period of 6.5 years. A subset of these subjects gained excessive weight. We tested for association of polymorphisms in 8 candidate genes with the above trait. We found the Gly482Ser polymorphism in the peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC1alpha) to be significantly associated with weight gain in males (P = .0045) but not in females. The Ser allele was associated with greater weight gain than the Gly allele (P = .005). Subjects with a family history of type 2 diabetes mellitus (T2DM) were more common among those who gained excessive weight. We conclude that T2DM and the Gly482Ser polymorphism in PGC1alpha contribute to the effect of intensive diabetes therapy on weight gain in males with T1DM. FAU - Deeb, Samir S AU - Deeb SS AD - Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA 98195-7720, USA. sdeeb@u.washington.edu FAU - Brunzell, John D AU - Brunzell JD LA - eng GR - P01 DK002456/DK/NIDDK NIH HHS/United States GR - P30 DK017047/DK/NIDDK NIH HHS/United States PT - Journal Article DEP - 20090407 PL - United States TA - PPAR Res JT - PPAR research JID - 101269101 PMC - PMC2666270 EDAT- 2009/04/11 09:00 MHDA- 2009/04/11 09:01 PMCR- 2009/04/07 CRDT- 2009/04/11 09:00 PHST- 2008/12/13 00:00 [received] PHST- 2009/01/14 00:00 [accepted] PHST- 2009/04/11 09:00 [entrez] PHST- 2009/04/11 09:00 [pubmed] PHST- 2009/04/11 09:01 [medline] PHST- 2009/04/07 00:00 [pmc-release] AID - 10.1155/2009/649286 [doi] PST - ppublish SO - PPAR Res. 2009;2009:649286. doi: 10.1155/2009/649286. Epub 2009 Apr 7.